BaFin Warns Consumers About Unauthorized Website

The German Federal Financial Supervisory Authority (BaFin) has issued a warning to consumers regarding the website europecapitalmarkets(.)com. BaFin has received information indicating that the operators are conducting banking business and/or financial services without the necessary authorization and are not supervised by BaFin.

BaFin Notice on Cyber Insurance Fluctuation Reserves

Germany's BaFin has issued a notice clarifying conditions for establishing fluctuation reserves for cyber insurance. The notice addresses how the separate profit and loss statement for cyber insurance, effective end of 2025, impacts reserve formation based on a seven-year observation period.

BaFin Warns of VYNEX Trade WhatsApp Group Offers

Germany's financial regulator, BaFin, has issued a warning regarding VYNEX Trade, which is operating unauthorized financial and crypto-asset services through WhatsApp groups and the Lirunex Trading app. The warning highlights potential investment fraud and advises consumers to exercise extreme caution.

BaFin Notice on Cyber Insurance Fluctuation Reserves

The German Federal Financial Supervisory Authority (BaFin) has issued a regulatory notice regarding the formation of fluctuation reserves for standalone cyber insurance. This notice provides guidance on the requirements and implications for insurers offering cyber insurance products, based on industry data from 2020-2024.

BaFin Warns of Unauthorized Financial Services by Mjolnex

Germany's financial regulator, BaFin, has issued a warning regarding the website mjolnex-ltd.com, operated by Mjolnex, which is allegedly offering unauthorized financial and crypto-asset services. The warning serves to alert consumers to potential fraudulent activities and to emphasize the requirement for BaFin authorization for such services.

BaFin Warns Mjolnex Offers Unauthorized Financial Services

Germany's Federal Financial Supervisory Authority (BaFin) has issued a warning against Mjolnex for allegedly offering financial, investment, and crypto asset services without the required authorization. The warning targets offers made on the website mjolnex-ltd(.)com.

BaFin Warns Against VYNEX Trade Offers on WhatsApp

Germany's BaFin has issued a warning against VYNEX Trade, which is allegedly offering unauthorized financial and crypto-asset services via WhatsApp groups and the Lirunex Trading app. BaFin advises consumers to exercise extreme caution and verify authorization before investing.

BaFin Warns of Unauthorized Investment Offers on WhatsApp

Germany's BaFin has issued a warning regarding unauthorized investment offers from Prometheus Investment Alliance (PIA) being promoted on WhatsApp. The firm allegedly operates without the necessary authorization to offer financial instruments and crypto-asset services, potentially engaging in investment fraud.

BaFin Warns Against Unauthorised Prometheus Investment Alliance Offers

The German Financial Supervisory Authority (BaFin) has issued a warning against Prometheus Investment Alliance (PIA) for allegedly offering unauthorised financial and cryptoasset services. PIA is suspected of deceiving consumers through WhatsApp groups and a website, directing them to trade via the QVTcoinese-Pro app.

Chavez v. Friendly Wash IV et al - Civil Case Filing

A civil case, Chavez v. Friendly Wash IV et al, was filed on March 12, 2026, in the U.S. District Court for the Northern District of California. The case involves claims related to the Americans with Disabilities Act. The initial filing includes a complaint and proposed summons.

GSA Advances Coburn Gore, Maine Land Port of Entry Project

The U.S. General Services Administration (GSA) announced a milestone for the Coburn Gore, Maine Land Port of Entry expansion project. The Final Environmental Assessment with a Finding of No Significant Impact has been completed, clearing the way for the next phase of modernization. Construction is scheduled to begin in the summer of 2028.

Campbell v. United States - Criminal Appeal

The D.C. Court of Appeals reviewed a criminal conviction for assault. While affirming the sufficiency of evidence to disprove self-defense, the court found the trial court erred by not inquiring into the defendant's decision to forgo an insanity defense. The case is remanded for this inquiry.

Capitol Intelligence Group v Waldman - Defamation Appeal

The DC Court of Appeals reversed a lower court's denial of an Anti-SLAPP motion in a defamation case. The court found that the plaintiff did not adduce sufficient evidence of falsity or actual malice to survive the motion, reversing the partial denial and remanding the case.

Hernandez v. DC Board of Zoning Adjustment Opinion

The DC Court of Appeals affirmed the Board of Zoning Adjustment's decision to grant a special exception for a theoretical subdivision, allowing multiple principal buildings on a single lot. The court disagreed with petitioners' assertion that the Board could not grant the exception while denying a variance for lot width requirements.

Primal Herbs Recalls Volume Due to Undeclared Sildenafil

Primal Supplements Group LLC is voluntarily recalling all orders of Primal Herbs Volume due to the undeclared presence of sildenafil, an active ingredient in Viagra. The FDA confirmed the undeclared ingredient, which poses a risk of dangerous blood pressure drops when interacting with nitrates.

TVA Employee Compensation Limit Memorandum

President Trump issued a Presidential Memorandum directing the Tennessee Valley Authority (TVA) Board of Directors to implement a maximum total annual compensation limit of $500,000 for all TVA employees. This directive aims to promote fiscal responsibility and align TVA compensation with public-sector standards.

US Sanctions Hamas Illicit Charity Network

The U.S. Department of State announced sanctions against four illicit charities funding Hamas militants. These actions, taken under Executive Order 13224, aim to disrupt funding sources for terrorist activities and expose Hamas's use of civilian organizations. The sanctions are part of ongoing efforts to combat terrorism.

US Sanctions Target DPRK IT Worker Schemes Defrauding Businesses

The U.S. Department of State and Treasury have sanctioned two entities and six individuals for their involvement in schemes using North Korean IT workers to generate revenue for the DPRK's weapons programs. These operations systematically defraud U.S. businesses and fund illicit WMD and ballistic missile development.

TRA Investigation on US HVO Biodiesel - Negative Determination

The UK's Trade Remedies Authority (TRA) has completed its investigation into US HVO biodiesel and proposes a final negative determination, meaning no countervailing measure will be imposed. The TRA concluded that the Blenders Tax Credit subsidy programme no longer offers subsidisation to US exporters.

UK Imposes Anti-Dumping Measure on Chinese Tin Mill Imports

The UK Government has accepted the Trade Remedies Authority's recommendation to impose new anti-dumping measures on imports of tin mill products from China. Duties of 27.85% and 49.98% will be applied to protect the UK's tin mill industry from injury caused by dumped imports.

OFLC Webinar on CW-1 Application Process

The Office of Foreign Labor Certification (OFLC) is hosting a webinar on March 25, 2026, to provide technical assistance on filing CW-1 applications for employment in the Commonwealth of the Northern Mariana Islands. The session will cover application preparation, recruitment, and common post-filing issues.

CHIPS R&D Standardization Readiness Level Workshop Summary Report

The National Institute of Standards and Technology (NIST) has published a summary report from the CHIPS R&D Standardization Readiness Level Workshop. The report details discussions and findings related to standardization frameworks for semiconductors and microelectronics.

DEC Region 8 Announces Naples Creek Rainbow Trout Sampling

The New York State Department of Environmental Conservation (DEC) Region 8 announced its annual rainbow trout sampling event for Naples Creek on March 19, 2026. This event is part of the region's fisheries management practices and provides an educational opportunity for the public.

DEC Awards $3.2M for Adirondack Park Smart Growth Initiatives

The New York State Department of Environmental Conservation (DEC) announced over $3.2 million in grant awards to 26 communities and organizations in the Adirondack Park. These funds will support smart growth initiatives, including affordable housing, recreational access, and economic development compatible with environmental protection.

Professional Recovery Network, Fees and CE Updates

Professional Recovery Network, Fees and CE Updates

Texas Pharmacy and Medical Boards Joint Statement on Communication

The Texas Medical Board and Texas State Board of Pharmacy issued a joint statement reminding physicians and pharmacists of the importance of clear communication and collaboration in patient care. The statement emphasizes professional judgment and shared responsibility in ensuring safe and legitimate prescription practices.

Rule, Disciplinary Action, & Remedial Plan Summaries

Rule, Disciplinary Action, & Remedial Plan Summaries

DEA Extensions, eRX Fraud Prevention, HB25 Enacted

This notice from the Texas State Board of Pharmacy (TSBP) covers several key updates. It mentions the enactment of HB25, extensions related to the DEA, and measures for e-prescribing fraud prevention. The content appears to be a summary of recent regulatory and legislative changes relevant to pharmacy practice.

Texas Pharmacy Rules Updated

The Texas State Board of Pharmacy has updated its rules following a recent board meeting. This notice serves to inform stakeholders about the changes made to existing pharmacy regulations.

WHO Handbook Accelerates Hepatitis Elimination Action

The World Health Organization (WHO) has released a new implementation handbook to support countries in accelerating action towards hepatitis elimination by 2030. The handbook consolidates evidence-based recommendations and provides practical guidance for expanding prevention, testing, and treatment services.

WHO Releases New Antibiotic Profiles for Drug-Resistant Infections

The World Health Organization (WHO) has released three new Target Product Profiles (TPPs) for antibacterial agents to address critical drug-resistant infections. These profiles guide the development of new antibiotics for multidrug-resistant Gram-negative infections, Gram-positive infections in vulnerable patients, and bacterial meningitis.

Teva Octreotide Recalled Due to Manufacturing Deficiencies

Health Canada has issued a Type I drug recall for Teva Octreotide due to manufacturing site deficiencies identified at a foreign facility. These deficiencies could lead to potential quality issues, including compromised sterility and dosing accuracy. The recall is a precautionary measure.

Health Canada Health Product InfoWatch - February 2026

Health Canada's February 2026 Health Product InfoWatch includes a monthly recap of safety information, including a recall of Teva Octreotide and advisories on unauthorized products. It also announces a consultation on controlling zuranolone and new market authorizations with conditions.

Health Canada Health Product Safety Recap

Health Canada has issued its February 2026 Health Product InfoWatch, detailing recalls for Teva Octreotide due to GMP deficiencies and unauthorized health products. It also announces a consultation on controlling zuranolone under the Controlled Drugs and Substances Act.

PMDA Japan Drug Precaution Revisions

The PMDA Japan has updated drug precautions for several medications, including Andexanet alfa, Topiramate, and various VEGF/VEGFR inhibitors. These revisions reflect new safety information and investigation results, impacting the labeling and handling of these drugs.

Japan PMDA Drug Precaution Revisions for FY2025

The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has published a list of drug precaution revisions for Fiscal Year 2025, detailing updates for various nonproprietary drug names. These revisions are effective on specific dates in late 2025 and early 2026, with associated investigation summaries available.

HSA Charges Man for Trafficking Etomidate Vaporiser Pods

The Health Sciences Authority (HSA) of Singapore has charged a 34-year-old man for allegedly trafficking etomidate vaporiser pods. The charges follow an enforcement operation where HSA seized over 900 tablets, cough syrup, and etomidate-containing vaporiser pods. Stricter penalties for etomidate trafficking are in effect.

HSA Deepens International Partnerships for Biomedical Sector Growth

The Health Sciences Authority (HSA) of Singapore has announced deepened collaborations with Malaysia and Uzbekistan to facilitate access to medicines and medical devices. These partnerships include a formalised Medical Device Regulatory Reliance Programme with Malaysia and a Memorandum of Understanding with Uzbekistan for broader regulatory cooperation.

Therapeutic Product Approvals and Indications List Update

The Health Sciences Authority (HSA) of Singapore has published updated lists of new therapeutic product approvals and new indications for registered therapeutic products, effective March 2026. These lists are intended for healthcare professionals and industry members.

Raymond Chua's address at 29th Medical Device Regulators Forum

Raymond Chua's address at 29th Medical Device Regulators Forum

HSA Achieves WHO ML4 Recognition for Medical Devices, Expands Biomedical Role

The Health Sciences Authority (HSA) in Singapore has achieved the highest World Health Organization (WHO) Maturity Level (ML4) for medical devices regulatory systems, becoming the first national authority globally to do so. HSA is also expanding its economic role to support the biomedical sector's growth.

TGA Releases Compliance Principles for 2026-2027 Enforcement

The Therapeutic Goods Administration (TGA) has released its compliance principles for 2026-2027, outlining a refreshed, proactive, and risk-based approach to enforcement for therapeutic goods in Australia. The principles apply across all TGA-regulated areas and will be reviewed every two years.

TGA Seizes Illegal Vapes Sold to Young People

The Therapeutic Goods Administration (TGA) in Australia, with police support, seized illegal vaping products from a store in Inverloch, Victoria, allegedly sold to minors. The TGA is investigating further regulatory action and warns retailers against targeting young people with illicit vapes.

TGA Seizes 57,000 Illegal Vaping Goods in NSW Crackdown

The Therapeutic Goods Administration (TGA) in Australia, with law enforcement support, seized over 57,000 illegal vaping products in Burwood, NSW. This action targets the illicit supply of vapes, with significant penalties including fines and imprisonment for non-compliance with the Therapeutic Goods Act 1989.

Prime Medic Group Fined for Unlawful Weight Loss Medicine Advertising

The Therapeutic Goods Administration (TGA) has issued infringement notices totaling $23,760 to Prime Medic Group and an individual for allegedly unlawfully advertising prescription-only weight loss medicines. Prime Medic Group paid the fines in January 2026.

TGA Issues Infringement Notices for Unlawful Importation and Advertising

The Therapeutic Goods Administration (TGA) has issued 11 infringement notices totaling $43,560 to 6 individuals for alleged unlawful importation of unapproved therapeutic goods and unlawful advertising of prescription-only medicines. These actions underscore the TGA's commitment to protecting public health.

TGA Safety Alert: Ayurvedic Tablets Contain High Heavy Metals

The Therapeutic Goods Administration (TGA) has issued a safety alert regarding Kumar Kalyan Rasa tablets, an Ayurvedic medicine. Testing revealed extremely high concentrations of heavy metals, including mercury, lead, arsenic, and cadmium, posing serious health risks to consumers, particularly pregnant women and children. The TGA urges consumers to exercise extreme caution with such products.

TGA Safety Alert: Counterfeit Botox Vials Continue to be Imported

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding the continued importation of counterfeit Botox vials into Australia. These products, packaged to appear genuine but confirmed as fake by AbbVie, pose significant public health risks and cannot be legally imported under any circumstances.

Safety Concerns Over Imported Counterfeit Melatonin Products

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding imported counterfeit unregistered melatonin products. Laboratory testing revealed significant discrepancies in melatonin content, with some products containing over 400% of the labelled amount and others none at all, posing serious risks to consumers, especially children.

TGA Safety Advisory: Counterfeit GLP-1 Weight Loss Products

The Therapeutic Goods Administration (TGA) has issued an updated safety advisory regarding counterfeit weight loss products falsely claiming to contain GLP-1 receptor agonists. Laboratory testing confirmed these products contain no active GLP-1 ingredients and are not included in the Australian Register of Therapeutic Goods.